103 related articles for article (PubMed ID: 27085391)
1. Polyautoimmunity in autoimmune gastritis.
Kalkan Ç; Soykan I
Eur J Intern Med; 2016 Jun; 31():79-83. PubMed ID: 27085391
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with elevated serum chromogranin A levels in patients with autoimmune gastritis.
Kalkan Ç; Karakaya F; Soykan İ
Turk J Gastroenterol; 2016 Nov; 27(6):515-520. PubMed ID: 27852542
[TBL] [Abstract][Full Text] [Related]
3. Are patients with autoimmune thyroid disease and autoimmune gastritis at risk of gastric neuroendocrine neoplasms type 1?
Alexandraki KI; Nikolaou A; Thomas D; Syriou V; Korkolopoulou P; Sougioultzis S; Kaltsas G
Clin Endocrinol (Oxf); 2014 May; 80(5):685-90. PubMed ID: 24118101
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of gastrin levels for the diagnosis of gastric enterochromaffin-like cell hyperplasia in patients with Hashimoto's thyroiditis.
Nicolaou A; Thomas D; Alexandraki KI; Sougioultzis S; Tsolakis AV; Kaltsas G
Neuroendocrinology; 2014; 99(2):118-22. PubMed ID: 24776735
[TBL] [Abstract][Full Text] [Related]
5. Differences between older and young patients with autoimmune gastritis.
Kalkan Ç; Soykan I
Geriatr Gerontol Int; 2017 Jul; 17(7):1090-1095. PubMed ID: 27444719
[TBL] [Abstract][Full Text] [Related]
6. Chromogranin A as a useful neuroendocrine marker in patients with autoimmune Addison's disease.
El Ali Z; Fichna M; Piniewska J; Kosowicz J; Grzymisławski M
J Endocrinol Invest; 2010 Mar; 33(3):186-91. PubMed ID: 19794299
[TBL] [Abstract][Full Text] [Related]
7. Serum ghrelin as a marker of atrophic body gastritis in patients with parietal cell antibodies.
Checchi S; Montanaro A; Pasqui L; Ciuoli C; Cevenini G; Sestini F; Fioravanti C; Pacini F
J Clin Endocrinol Metab; 2007 Nov; 92(11):4346-51. PubMed ID: 17711921
[TBL] [Abstract][Full Text] [Related]
8. Occurrence and risk factors for autoimmune thyroid disease in patients with atrophic body gastritis.
Lahner E; Centanni M; Agnello G; Gargano L; Vannella L; Iannoni C; Delle Fave G; Annibale B
Am J Med; 2008 Feb; 121(2):136-41. PubMed ID: 18261502
[TBL] [Abstract][Full Text] [Related]
9. Netazepide, a gastrin/cholecystokinin-2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis.
Boyce M; Moore AR; Sagatun L; Parsons BN; Varro A; Campbell F; Fossmark R; Waldum HL; Pritchard DM
Br J Clin Pharmacol; 2017 Mar; 83(3):466-475. PubMed ID: 27704617
[TBL] [Abstract][Full Text] [Related]
10. Serum chromogranin A level continuously rises with the progression of type 1 diabetes, and indicates the presence of both enterochromaffin-like cell hyperplasia and autoimmune gastritis.
Herold Z; Herold M; Nagy P; Patocs A; Doleschall M; Somogyi A
J Diabetes Investig; 2020 Jul; 11(4):865-873. PubMed ID: 31883432
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and predictors of colonoscopic findings in patients with autoimmune gastritis.
Asfuroglu Kalkan E; Kalkan C; Gumussoy M; Gucbey O; Soykan I
J Investig Med; 2022 Jan; 70(1):73-78. PubMed ID: 34341100
[TBL] [Abstract][Full Text] [Related]
12. Netazepide, a gastrin receptor antagonist, normalises tumour biomarkers and causes regression of type 1 gastric neuroendocrine tumours in a nonrandomised trial of patients with chronic atrophic gastritis.
Moore AR; Boyce M; Steele IA; Campbell F; Varro A; Pritchard DM
PLoS One; 2013; 8(10):e76462. PubMed ID: 24098507
[TBL] [Abstract][Full Text] [Related]
13. A laboratory score in the diagnosis of autoimmune atrophic gastritis: a prospective study.
Miceli E; Padula D; Lenti MV; Gallia A; Albertini R; Di Stefano M; Klersy C; Corazza GR
J Clin Gastroenterol; 2015 Jan; 49(1):e1-5. PubMed ID: 24583750
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of autoimmune atrophic gastritis in vitiligo.
Zauli D; Tosti A; Biasco G; Miserocchi F; Patrizi A; Azzaroni D; Andriani G; Di Febo G; Callegari C
Digestion; 1986; 34(3):169-72. PubMed ID: 3758513
[TBL] [Abstract][Full Text] [Related]
15. Fundic argyrophil cell hyperplasia in atrophic gastritis: a search for a sensitive diagnostic method.
Belaiche J; Delwaide J; Vivario M; Gast P; Louis E; Boniver J
Acta Gastroenterol Belg; 1993; 56(1):11-7. PubMed ID: 7688175
[TBL] [Abstract][Full Text] [Related]
16. Plasma chromogranin A in patients with autoimmune chronic atrophic gastritis, enterochromaffin-like cell lesions and gastric carcinoids.
Peracchi M; Gebbia C; Basilisco G; Quatrini M; Tarantino C; Vescarelli C; Massironi S; Conte D
Eur J Endocrinol; 2005 Mar; 152(3):443-8. PubMed ID: 15757862
[TBL] [Abstract][Full Text] [Related]
17. [Influence of long-term gastric acid suppression therapy on the expression of serum gastrin, chromogranin A, and ghrelin].
Kim BW; Lee BI; Kim HK; Cho YS; Chae HS; Lee HK; Kim HJ; Han SW
Korean J Gastroenterol; 2009 Feb; 53(2):84-9. PubMed ID: 19237833
[TBL] [Abstract][Full Text] [Related]
18. The various faces of autoimmune endocrinopathies: non-tumoral hypergastrinemia in a patient with lymphocytic colitis and chronic autoimmune gastritis.
Melcescu E; Hogan RB; Brown K; Boyd SA; Abell TL; Koch CA
Exp Mol Pathol; 2012 Dec; 93(3):434-40. PubMed ID: 23043903
[TBL] [Abstract][Full Text] [Related]
19. Atrophic autoimmune pangastritis: A distinctive form of antral and fundic gastritis associated with systemic autoimmune disease.
Jevremovic D; Torbenson M; Murray JA; Burgart LJ; Abraham SC
Am J Surg Pathol; 2006 Nov; 30(11):1412-9. PubMed ID: 17063082
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune gastritis presenting as iron deficiency anemia in childhood.
Gonçalves C; Oliveira ME; Palha AM; Ferrão A; Morais A; Lopes AI
World J Gastroenterol; 2014 Nov; 20(42):15780-6. PubMed ID: 25400463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
